Stock IMP A SDB IMPLANTICA AG
Add to a list
To use this feature you must be a member
Log inSign up

All News Implantica AG

Equities

IMP A SDB

SE0014855029

Market Closed - Nasdaq Stockholm
Other stock markets
 08:54:20 26/04/2024 pm IST 		5-day change 1st Jan Change
27.5 SEK +0.18% Intraday chart for Implantica AG -5.17% +15.06%
27/03 Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device MT
27/03 Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module) CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Implantica Submits Initial Module of US FDA Premarket Approval Application for GERD Medical Device
MT
Implantica Submits U.S. FDA Premarket Approval Application for RefluxStop® (first module)
CI
Implantica Completes Human Factors Validation Study for RefluxStop as Part of the US FDA Premarket Approval Process
CI
Implantica to Deploy GERD Treatment in Spain
MT
Implantica AG (publ.) Wins Another RefluxStop Public Tender in Europe with Hospital Universitario De Getafe
CI
Implantica AG (OM:IMP A SDB) acquired IRCCS Saverio De Bellis.
CI
Transcript : Implantica AG, Q4 2023 Earnings Call, Feb 16, 2024
Implantica AG Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Implantica Announces Completion of its First RefluxStop Procedures at Artemed Klinikum München Süd in Munich, Germany
CI
Implantica Announces First Refluxstop Public Tender Win, Paving the Way for Permanent Reimbursement in Italy
CI
Implantica Ag Announces the First RefluxStop Procedures Completed At MIC Hospital in Berlin
CI
Implantica AG (publ.) Adds Another RefluxStop Center in Spain
CI
Transcript : Implantica AG, Q3 2023 Earnings Call, Nov 22, 2023
Implantica AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Implantica AG (publ.)'s RefluxStop Offers for the First Time in the NHS in UK
CI
Implantica Wins EU Medical Device Certifications
MT
Implantica AG Receives MDR Certification for RefluxStop?
CI
Transcript : Implantica AG, Q2 2023 Earnings Call, Aug 24, 2023
Implantica AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Implantica AG Further Expands Its Commercial Footprint in Italy
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMP A SDB Stock
  4. News Implantica AG